Copyright
©The Author(s) 2022.
World J Psychiatry. Mar 19, 2022; 12(3): 521-532
Published online Mar 19, 2022. doi: 10.5498/wjp.v12.i3.521
Published online Mar 19, 2022. doi: 10.5498/wjp.v12.i3.521
Table 2 Response measured as Positive and Negative Syndrome Scale total score improvement from baseline
| Baseline PANSS total score | 1 wk1 | 3 wk1 | 6 wk1 | 12 wk1 | 26 wk1 | 39 wk1 | 52 wk1 | |
| Strong response group | 99.7 | 12.0 (17.2%) | 26.6 (38.2%) | 33.5 (48.1%) | 42.4 (60.8%) | 48.3 (69.3%) | 56.7 (81.3%) | 57.5 (82.5%) |
| Good response group | 73.3 | 10.2 (23.5%) | 16.3 (37.6%) | 19.3 (44.7%) | 19.8 (45.8%) | 23.4 (54%) | 25.8 (59.6%) | 25.7 (59.4%) |
| Slight response group | 86.1 | 3.5 (6.2%) | 9.0 (16%) | 1.5 (2.7%) | 6.4 (11.3%) | 1.7 (3%) | 7.5 (13.4%) | 7.6 (13.6%) |
| Total | 78.4 | 9.9 (20.5%) | 16.7 (34.5%) | 18.4 (38%) | 20.7 (42.6%) | 22.1 (45.6%) | 26.4 (54.4%) | 27.2 (56.2%) |
- Citation: Drosos P, Johnsen E, Bartz-Johannessen CA, Larsen TK, Reitan SK, Rettenbacher M, Kroken RA. Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness. World J Psychiatry 2022; 12(3): 521-532
- URL: https://www.wjgnet.com/2220-3206/full/v12/i3/521.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i3.521